chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Pyrexia, Rash macular, Rash papular, Skin lesion, Tenderness
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 375785. A 26 year-old female patient received the following vaccines on 08 December 2009: a percutaneous injection of ACAM2000 (lot number not reported); and anthrax vaccine (other manufacturer, lot number FAV219). Nine days after vaccination, the patient developed redness over the nose and cheeks which was followed by tingling and papular lesions around the upper and lower lips. The following day, additional lesions appeared on the forehead, right cheek and left outer ear. There were no oral lesions or painful swallowing. The lesions increased around the lips on Day 10. The patient reports that the ACAM2000 vaccination site remained covered until approximately Day 5 when a vesicle was noted at the site and it remained covered since then. She denies scratching or rubbing the site. The patient was evaluated by dermatology on Day 10. She was afebrile. The lesions at this time were described as follows: multiple grouped papules distributed around upper and lower lip borders, some on erythematous base and some mildly coalesced; 2 papules above upper lip; 1 on left outer ear; 1 on right cheek; 2 on forehead; and a shiny macular plaque across nose and both cheeks. A robust take was noted at the ACAM2000 vaccination site with mild tenderness in the left axillary area. The preliminary diagnosis was possible autoinoculation. VALTREX was prescribed. A viral culture was positive for herpes simplex virus; a bacterial culture was negative; and vaccinia PCR was negative. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number has been verified as an ACAM2000 lot number. List of documents held by sender: none.
Age: 26.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Bacterial test negative, Cardiac pacemaker insertion, Erythema, Herpes simplex serology positive, Injection site pain
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 375785. A 26 year-old female patient received the following vaccines on 08 December 2009: a percutaneous injection of ACAM2000 (lot number not reported); and anthrax vaccine (other manufacturer, lot number FAV219). Nine days after vaccination, the patient developed redness over the nose and cheeks which was followed by tingling and papular lesions around the upper and lower lips. The following day, additional lesions appeared on the forehead, right cheek and left outer ear. There were no oral lesions or painful swallowing. The lesions increased around the lips on Day 10. The patient reports that the ACAM2000 vaccination site remained covered until approximately Day 5 when a vesicle was noted at the site and it remained covered since then. She denies scratching or rubbing the site. The patient was evaluated by dermatology on Day 10. She was afebrile. The lesions at this time were described as follows: multiple grouped papules distributed around upper and lower lip borders, some on erythematous base and some mildly coalesced; 2 papules above upper lip; 1 on left outer ear; 1 on right cheek; 2 on forehead; and a shiny macular plaque across nose and both cheeks. A robust take was noted at the ACAM2000 vaccination site with mild tenderness in the left axillary area. The preliminary diagnosis was possible autoinoculation. VALTREX was prescribed. A viral culture was positive for herpes simplex virus; a bacterial culture was negative; and vaccinia PCR was negative. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number has been verified as an ACAM2000 lot number. List of documents held by sender: none.
Age: 26.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Injection site vesicles, Paraesthesia, Polymerase chain reaction, Rash papular, Robust take following exposure to vaccinia virus
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 375785. A 26 year-old female patient received the following vaccines on 08 December 2009: a percutaneous injection of ACAM2000 (lot number not reported); and anthrax vaccine (other manufacturer, lot number FAV219). Nine days after vaccination, the patient developed redness over the nose and cheeks which was followed by tingling and papular lesions around the upper and lower lips. The following day, additional lesions appeared on the forehead, right cheek and left outer ear. There were no oral lesions or painful swallowing. The lesions increased around the lips on Day 10. The patient reports that the ACAM2000 vaccination site remained covered until approximately Day 5 when a vesicle was noted at the site and it remained covered since then. She denies scratching or rubbing the site. The patient was evaluated by dermatology on Day 10. She was afebrile. The lesions at this time were described as follows: multiple grouped papules distributed around upper and lower lip borders, some on erythematous base and some mildly coalesced; 2 papules above upper lip; 1 on left outer ear; 1 on right cheek; 2 on forehead; and a shiny macular plaque across nose and both cheeks. A robust take was noted at the ACAM2000 vaccination site with mild tenderness in the left axillary area. The preliminary diagnosis was possible autoinoculation. VALTREX was prescribed. A viral culture was positive for herpes simplex virus; a bacterial culture was negative; and vaccinia PCR was negative. The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number has been verified as an ACAM2000 lot number. List of documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Post vaccination autoinoculation
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 376790.  A 26 year-old male patient received smallpox ACAM2000, (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 29 December 2009.  Ten days post vaccination the patient reported lesions on left side of face below the eye and a lesion at the right temple.  At the time of the report, the lesions were still present and the patient was recovering.  The patient visited emergency care for this event.  No additional information was provided.  List of documents held by sender:  None
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Skin lesion
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 376790.  A 26 year-old male patient received smallpox ACAM2000, (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 29 December 2009.  Ten days post vaccination the patient reported lesions on left side of face below the eye and a lesion at the right temple.  At the time of the report, the lesions were still present and the patient was recovering.  The patient visited emergency care for this event.  No additional information was provided.  List of documents held by sender:  None
Age: 31.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Diarrhoea, Muscle spasms, Vomiting
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 377957. A 31 year-old female patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A) and anthrax (manufacturer unknown, lot number FAV198 on 19 January 2010. Five hours post vaccination (on the same day) the patient was brought to emergency care with bilateral upper extremity hand spasm, carpal pedial spasm, three episodes of vomiting and one episode of diarrhea. The patient denied any health issues. The patient was given SOLMEDROL 125 milligrams intramuscular injection and was educated on medication injection. It was reported that the patient would continue to be monitored. The outcome was not reported. No additional information was provided.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Dyspnoea, Pericarditis
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 378023. A 28 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 06 January 2010. Seven days post-vaccination starting on 13 January 2010 the patient reported chest pains and on 17 January 2010 reported shortness of breath. The patient was hospitalized and diagnosed with pericarditis. The outcome of the patient was reported as recovered. No additional information was provided. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: C-reactive protein decreased, C-reactive protein normal, Chest X-ray normal, Chest X-ray normal, Chest discomfort
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Chest pain, Dizziness, Dyspnoea, Echocardiogram abnormal, Electrocardiogram abnormal
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Fatigue, Headache, No reaction on previous exposure to drug, Red blood cell sedimentation rate normal, Sinus bradycardia
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Troponin I, Troponin I, Visual impairment, Wolff-Parkinson-White syndrome
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Blood test normal, C-reactive protein normal, Chest X-ray normal, Chest discomfort, Chest pain
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Dizziness, Dyspnoea, Dyspnoea exertional, Electrocardiogram abnormal, Fatigue
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Headache, Painful respiration, Red blood cell sedimentation rate normal, Sinus bradycardia, Troponin I
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: FLU(H1N1), SMALL, FLU(H1N1), SMALL
Symptoms: Wolff-Parkinson-White syndrome
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under reference number 379052. A 21 year old male patient received the following vaccines on 06 January 2010: ACAM2000 (lot number VV04003A); and pandemic H1N1 influenza vaccine (Novartis, lot number 102146P1A). On the same day in the evening, the patient reported shortness of breath with exertion. This was following a 6-mile run that afternoon. He also experienced a headache. The next morning (07 January 2010), after the patient had been awake for a little while, he noted non-exertional chest tightness and non-radiating pain on the right side of his chest. He noted that the pain was worse with deep breaths, but did not note any change in the chest pain with positional changes. He noted some lightheadedness with position changes and his headache continued. He mentioned this to his supervisor and was told to rest, so he engaged in minimal activity for most of that day. In the morning of 08 January 2010, the patient noted chest pain and tightness and continued to experience a headache after he awoke, so he sought evaluation of his symptoms. His headache was treated with VICODIN and a MEDROL-PACK. He was also given BENADRYL and placed on 24 hour rest in his quarters. He returned for evaluation on 12 January 2010, and he was still having some chest tightness and pressure (3/10 on pain scale), but his headache was resolved. He had an abnormal electrocardiogram which showed an incidental finding of WOLFF PARKINSON WHITE syndrome (WPW). He was instructed to return on 15 January 2010 and INDOCIN was prescribed. When he returned on 15 January 2010, his symptoms has significantly improved, but he still reported mild chest tightness with deep breaths and his repeat electrocardiogram showed WPW. Cardiology was consulted and the patient was scheduled for an echocardiogram with subsequent cardiology follow-up in early February. As of 22 January 2010, the patient denied any chest pain or tightness, but was experiencing some mild shortness of breath and fatigue. He reported that he had been experiencing headaches daily over the past 10 days. The patient reported a history of migraine headaches which started when he was in 10th grade. The following findings were reported. On 15 January 2010, the patient had a CRP, 0.8; Troponin I Cardiac, <0.012 ng/m; and ESR, 6. On 12 January 2010, the patient had a normal chest X-ray and an electrocardiogram with sinus bradycardia at 49 bpm and an incidental findings of WPW syndrome. On 15 January 2010, an electrocardiogram also showed sinus bradycardia and WPW syndrome. Note: There may be a discrepancy between the event date filed and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 35.0
Sex: M
Vaccine: ANTH, FLUX(H1N1), SMALL, TYP, ANTH, FLUX(H1N1), SMALL, TYP
Symptoms: Convulsion, Loss of consciousness, Loss of consciousness
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under the reference number 379293. A 35 year-old male patient received the following vaccines on 03 February 2010: ACAM2000 (lot number VV04003A); pandemic influenza vaccine (manufacturer unknown, lot number not reported); typhoid vaccine (manufacturer unknown, lot number not reported); and BIOTHRAX (Emergent Biosolutions, lot number not reported). On the same day, after receiving the last dose of vaccine which was BIOTHRAX, the patient lost consciousness and then went into convulsions which lasted 1 minute. The patient regained consciousness for 1 minute and then experienced another episode of lost consciousness and convulsions lasting 1 minute. The patient regained consciousness and was transported to the Emergency Room. No additional information was provided. List of documents held by sender: none.
Age: 35.0
Sex: M
Vaccine: ANTH, FLUX(H1N1), SMALL, TYP, ANTH, FLUX(H1N1), SMALL, TYP
Symptoms: Convulsion, Loss of consciousness
Clinical narrative: This case was received on 10 May 2010 via a QScan search on the VAERS database, under the reference number 379293. A 35 year-old male patient received the following vaccines on 03 February 2010: ACAM2000 (lot number VV04003A); pandemic influenza vaccine (manufacturer unknown, lot number not reported); typhoid vaccine (manufacturer unknown, lot number not reported); and BIOTHRAX (Emergent Biosolutions, lot number not reported). On the same day, after receiving the last dose of vaccine which was BIOTHRAX, the patient lost consciousness and then went into convulsions which lasted 1 minute. The patient regained consciousness for 1 minute and then experienced another episode of lost consciousness and convulsions lasting 1 minute. The patient regained consciousness and was transported to the Emergency Room. No additional information was provided. List of documents held by sender: none.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Chest pain, Chills, Fatigue, Pyrexia, Rash
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Vomiting
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Arthralgia, Blood albumin decreased, Blood cholesterol increased, Blood glucose increased, Blood potassium increased
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Blood sodium decreased, C-reactive protein increased, Chest pain, Chills, Echocardiogram abnormal
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Fatigue, Haematocrit decreased, Haemoglobin decreased, Lymphocyte count decreased, Myalgia
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Neutrophil count increased, Platelet count increased, Protein total decreased, Pyrexia, Rash
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Red blood cell count decreased, Red blood cell sedimentation rate increased, Vomiting, White blood cell count increased
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Chills, Electrocardiogram abnormal, Pyrexia, Rash, Tachycardia
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379616. A 42 year-old male patient received ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A.) on 30 January 2010. Three day post-vaccination the patient experienced chest pain, fatigue, fever, chills, disseminated rash, vomiting, myalgia and arthralgia. It was reported that the patient was hospitalized. Diagnostic and laboratory tests performed on 02 February 2010 included an abnormal echocardiogram; C-reactive protein increased; decreased hemoglobin; blood potassium increased; blood cholesterol increased; blood sodium decreased; red blood cell sedimentation rate increased; blood glucose increased; hematocrit decreased; neutrophil count increased; white blood cell count increased; platelet count increased; blood albumin decreased; lymphocyte count decreased; total protein decreased and red blood cell count decreased. No additional information was provided. List of documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, FLU(H1N1), SMALL, TYP, ANTH, FLU(H1N1), SMALL, TYP
Symptoms: Eye discharge, Ocular hyperaemia, Photosensitivity reaction
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379649. A 26 year-old male patient received the following vaccines: ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A), anthrax (unknown manufacturer, lot number FAV214), influenza H1N1 (Novartis Vaccines and Diagnostics, lot number 104040P1) and typhoid VI polysaccharide (manufacturer unknown, lot number E20131) on 06 January 2010. Fourteen days post vaccination the patient reported that his right eye was starting to turn red with clear drainage. The following day he experienced increased redness and drainage and over the following weekend it spread to his left eye. The patient denied pain or problems with vision but reported photosensitivity and continuing drainage (which remained clear). The patient also reported that the vaccination area on his arm was almost healed and had very little drainage. He said that he kept the site covered at all times and practiced frequent handwashing. The patient saw an ophthalmologist who placed him on steroid eye drops and antibiotics. The patient recovered. No additional information was provided.
Age: 26.0
Sex: M
Vaccine: ANTH, FLU(H1N1), SMALL, TYP, ANTH, FLU(H1N1), SMALL, TYP
Symptoms: Eye discharge, Injection site discharge, Ocular hyperaemia, Photosensitivity reaction
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379649. A 26 year-old male patient received the following vaccines: ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A), anthrax (unknown manufacturer, lot number FAV214), influenza H1N1 (Novartis Vaccines and Diagnostics, lot number 104040P1) and typhoid VI polysaccharide (manufacturer unknown, lot number E20131) on 06 January 2010. Fourteen days post vaccination the patient reported that his right eye was starting to turn red with clear drainage. The following day he experienced increased redness and drainage and over the following weekend it spread to his left eye. The patient denied pain or problems with vision but reported photosensitivity and continuing drainage (which remained clear). The patient also reported that the vaccination area on his arm was almost healed and had very little drainage. He said that he kept the site covered at all times and practiced frequent handwashing. The patient saw an ophthalmologist who placed him on steroid eye drops and antibiotics. The patient recovered. No additional information was provided.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, TDAP, TYP, ANTH, SMALL, TDAP, TYP
Symptoms: Chills, Malaise, Migraine, Pain, Rhinorrhoea
Clinical narrative: This case was received by Sanofi Pasteur on 10 May 2010 via QScan search on the VAERS database under reference number 379784. A 26 year-old male patient received the following vaccines: ACAM2000 (Sanofi Pasteur Biologics Co., lot number VV04-003A), TYPHIM VI (Sanofi Pasteur, lot number B09802), anthrax (Emergent Biosolutions, lot number FAV223) and BOOSTRIX (GlaxoSmithKline, lot number AC52B049A) on 12 January 2010. Seven days post vaccination the patient reported runny nose, chills and aching. The patient also reported waking up with migraines (no prior history of headaches), extreme hangover type feeling and per the patient "just not feeling right". The patient did not seek medical care for this event. It was reported that the patient recovered. No additional information was provided.